Cardio-Nephrology Confluence of the Heart and Kidney in Clinical Practice /

• Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
• Άλλοι συγγραφείς: Rangaswami, Janani (Επιμελητής έκδοσης), Lerma, Edgar V. (Επιμελητής έκδοσης), Ronco, Claudio (Επιμελητής έκδοσης)
• Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
• Γλώσσα: English
• Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2017.
• Θέματα: Medicine.; Critical care medicine.; Cardiology.; Nephrology.; Medicine & Public Health.; Intensive / Critical Care Medicine.

Extending from the outpatient management of cardiovascular and kidney disease, to hospital-based decision making in patients with cardio-renal disease and complex interfaces such as hemodialysis in patients with ventricular assist device support, this book serves as a single reference point for card...

Πίνακας περιεχομένων:

• PART I: CARDIOVASCULAR DISEASE SPECTRUM IN CHRONIC KIDNEY DISEASE
• Chapter 1 Endothelial Dysfunction and Nitric Oxide: Albuminuria as a Central Marker
• Chapter 2 Vascular and Valvular Calcification in Chronic Kidney Disease: Pathogenesis and Clinical Outcomes
• Chapter 3 Sudden Cardiac Death in CKD and ESKD: Risk Factors, Mechanisms, and Therapeutic Strategies
• Chapter 4 Coronary Artery Disease in CKD: Traditional and Nontraditional Risk Factors, Diagnosis and Management
• Chapter 5 CKD Associated Cardiomyopathy: Molecular Mechanisms, Imaging Modalities, Disease Evolution and Interventions
• PART II: CHRONIC KIDNEY DISEASE AND CAD: TWO SIDES OF THE SAME COIN
• Chapter 6 CKD as CAD Equivalent: Inflammatory Milieu and Vascular Oxidative Stress
• Chapter 7 Phosphorus and Mortality: Do we have the Panacea?
• Chapter 8 Inhibition of the Renin Angiotensin System: How far have we come?
• Chapter 9 Vitamin D and its Role in CKD and CAD: A Novel Therapeutic Target
• Chapter 10 Association of Catalytic (Labile) Iron with Cardiovascular Morbidity and Mortality
• Chapter 11 Erythropoietin and its Cardiovascular Effects
• PART III: CARDIO-RENAL SYNDROME
• Chapter 12 Pathophysiology of the Cardio-Renal Syndromes Types 1–5: Updates from the Eleventh Consensus Conference of the Acute Dialysis Quality Initiative (ADQI)
• Chapter 13 Hemodynamic Cross Talk in Cardiorenal Syndrome: Era of Biomarkers
• Chapter 14 Kidney Attack: Is NGAL Set to Take the Stage with Troponins?
• Chapter 15 Ultrafiltration Therapy in Decompensated Heart Failure
• Chapter 16 Bioimpedance Vectorial Analyses in Cardio Renal Syndrome
• Chapter 17 Novel Therapies for Acute Decompensated Heart Failure
• Chapter 18 Kidney Injury in Patients with Ventricular Assist Devices
• Chapter 19 Palliation with Dual Burden of Heart and Kidney Failure: An Underutilized Strategy
• PART IV: CARDIAC EVALUATION OF THE RENAL TRANSPLANT CANDIDATE
• Chapter 20 Screening Strategies for Coronary Artery Disease (CAD) in Candidates for Kidney Transplants
• Chapter 21 Cardiac Pre-Operative Evaluation as an Opportunity to Optimize Risk Factors in Kidney Transplant Candidates
• Chapter 22 Revascularization in Patients on the Renal Transplant List: When and What is Appropriate?
• Chapter 23 Pulmonary Hypertension in the Potential Kidney Transplant Recipient
• Chapter 24 Cardiac Surveillance whilst Listed for Renal Transplantation
• Chapter 25 Post Kidney Transplant Modification of Cardiovascular Risk
• Ch. 26 Cardiomyopathy in the Potential Kidney Transplant Candidate
• PART V: ANTICOAGULATION AND ANTIPLATELET THERAPY IN CKD
• Chapter 27 Anticoagulation in Patients with Atrial Fibrillation and Chronic Kidney Disease
• Chapter 28 Anticoagulation-Related Nephropathy: Tip of the Iceberg
• Chapter 29 Impact of Antiplatelet Therapy and Platelet Reactivity Testing on Cardiovascular Outcomes in Patients with Chronic Kidney Disease
• PART VI: INTERVENTIONAL STRATEGIES IN CARDIOVASCULAR DISEASE IN CKD
• Chapter 30 Revascularization Strategies in Chronic Kidney Disease: Percutaneous Coronary Intervention vs. Coronary Artery Bypass Graft Surgery
• Chapter 31 Revascularization Strategies in CKD: Anti-Platelet Therapy, Stent Type, Timing, and Complications of PCI
• Chapter 32 Peripheral Arterial Disease in CKD: Disease Burden, Outcomes and Interventional Strategies
• Chapter 33 Contrast Induced Nephropathy
• Chapter 34 Acute Kidney Injury after Cardiac Surgery
• PART VII: THE CARDIORENOMETABOLIC SPECTRUM
• Chapter 35 Dyslipidemias in CKD and ESKD: Outcomes and Management
• Chapter 36 The Cardiac Impact of Atherosclerotic Renovascular Disease (ARVD)
• Chapter 37 Preeclampsia: A Mirror into Future Cardiovascular and Renal Health
• Chapter 38 Obstructive Sleep Apnea: A Unifying Link between Cardiovascular and Renal Disease
• PART VIII: DILEMMAS IN HYPERTENSION
• Chapter 39 Chronic Kidney Disease and BP Goals
• Chapter 40 Renal Artery Stenosis: Diagnosis and Management
• Chapter 41 Renal Denervation: Current Opinions and Practice.